-
FDA Mulls Modifying Controversial Restrictions on Gay and Bisexual Blood Donors That Advocates Call ‘Outdated'
The federal Food and Drug Administration is considering further easing restrictions on blood donations by gay and bisexual men, a long criticized policy that first went into effect during the start of the AIDs pandemic, to focus instead on an individual risk of transmitting HIV....
The change would come as the country faces a continuing national blood shortage brought about by... -
HIV-Positive NYC Woman Becomes First To Get Heart Transplant From Donor Also With HIV
If there is a such thing as an ordinary heart transplant, this was not it. It marked the first time an HIV positive patient received a heart from an HIV positive donor.
-
Government Can't Mandate Coverage for Drugs That Prevent HIV Infections, Texas Federal Judge Rules
A federal judge in Texas has ruled that a provision of the Affordable Care Act that mandates free coverage of certain drugs that prevent HIV infections violates the religious beliefs of a Christian-owned company.
-
A 5th Person Is Likely Cured of HIV, and Another Is in Long-Term Remission
One case involved a man with cancer who underwent a specialized stem cell transplant; the other involved a woman who received immune-boosting therapies as part of a clinical trial.
-
Scientists Possibly Cured HIV in a Woman for the First Time
Following a cutting-edge treatment four years ago, the “New York patient” is now off of HIV medication and remains “asymptomatic and healthy,” researchers say.
-
Scientists Find Unrecognized Virulent HIV Variant: ‘Not a Public Health Crisis'
Scientists have found a previously unrecognized variant of HIV that’s more virulent than usual and has quietly spread in the Netherlands for the past few decades.
-
Moderna Launches Clinical Trial of Its mRNA HIV Vaccine
Nearly 60 participants were given their first doses of the experimental HIV vaccine Thursday
-
FDA Approves First Injectable HIV Prevention Drug
Apretude, the new drug, is an injectable given every two months as an alternative to HIV prevention pills.